Takahito Yamamoto

Differences in cytochrome P450 forms involved in the metabolism of N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100), a novel sigma ligand, in human liver and intestine.

K. Nagata, Y. Yamazoe, Masato Nakamura, 2003, Drug metabolism and disposition: the biological fate of chemicals.

Metabolism of N,N-dipropyl-2-[4-methoxy-3-(2-phenyl-ethoxy)-phenyl]-ethyl-amine-monohydrochloride (NE-100), a novel sigma ligand: contribution of cytochrome P450 forms involved in the formation of individual metabolites in human liver and small intestine.

K. Nagata, Y. Yamazoe, Masato Nakamura, 2003, Drug metabolism and pharmacokinetics.

Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns.

Y. Kohno, A. Suzuki, Takahito Yamamoto, 2002, Drug metabolism and pharmacokinetics.

Prediction of drug-drug interactions for AUCoral of high clearance drug from in vitro data: utilization of a microtiter plate assay and a dispersion model.

K. Nagata, Y. Yamazoe, Y. Kohno, 2006, Current drug metabolism.